Apimeds Pharmaceuticals US, Inc. SEC filings APUS
Apimeds Pharmaceuticals US, Inc. has 130 filings in SEC EDGAR's recent list, going back to Jan 29, 2024. Its latest annual report, Form 10-K, was filed on May 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 23, 2025 | — |
| 424B4 | Prospectus | May 9, 2025 | — |
| POS AM | Post-effective amendment | May 2, 2025 | — |
| POS AM | Post-effective amendment | May 1, 2025 | — |
| POS AM | Post-effective amendment | Apr 17, 2025 | — |
| FWP | Free writing prospectus | Feb 10, 2025 | — |
| S-1/A | Amended registration statement | Feb 10, 2025 | — |
| S-1/A | Amended registration statement | Feb 6, 2025 | — |
| S-1/A | Amended registration statement | Jan 29, 2025 | — |
| S-1/A | Amended registration statement | Jan 10, 2025 | — |
| S-1/A | Amended registration statement | Dec 20, 2024 | — |
| S-1/A | Amended registration statement | Dec 9, 2024 | — |
| S-1/A | Amended registration statement | Nov 8, 2024 | — |
| S-1 | Registration statement | Sep 25, 2024 | — |
Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APUS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Matawan, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1894525
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.